Concepta plc (AIM: CPT), the UK healthcare company and developer of a proprietary product targeted at the mobile health market with a primary focus on women’s fertility, is pleased to announce that it held its inaugural meeting to present its myLotus fertility product to potential distributors in Shanghai on 22 November 2017.
Concepta executives, alongside Chinese hospital partners, gave presentations on both the Company and its myLotus product, consisting of the myLotus meter, testing strips and app.
Leading doctors from both the Changhai and HuaShan hospitals also presented results of a hospital evaluation of the Company’s myLotus product. The results concluded that the LH and hCG2 measurements registered by myLotus achieved approximately 100% correlation with those of hospital laboratory tests carried out on blood samples. The results presented strong evidence of the product’s effectiveness to distributors, who will now assess the hospital route-to-market for myLotus.
31 potential distributors attended the meeting, covering 14 important cities and provinces1, including Beijing and Shanghai. Between them these distributors cover a total population of over 800 million people and have the potential to reach an estimated 2.8 million women with unexplained infertility.
Erik Henau, CEO of Concepta commented:
“With our distributor network in China expected to grow significantly next year, we intend to expand both of our UK and China based manufacturing sites to ramp up production. We have conducted an extensive review to ensure that the supply chain is operating at an optimum level to meet demand, and we will continue to adjust as demand increases.
“We are extremely pleased with the reception that our myLotus product received at the meeting. Over the coming months, Concepta’s team in China will be presenting full product demonstrations at the premises of each of the potential distributors as they prepare their business plans for their province.
“We anticipate 2018 to be a transformational year in which we build our distribution network throughout China as well as our direct to consumer launch in Europe, and look forward to updating the market on these developments in the New Year.”
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned